Certified by Founder Lodge
AAVantgarde Bio
Italy - Milan, Lombardy
START UP
1 Disclosed Funding Rounds $65,333,745
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Delivering the next generation gene therapies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 07 ,2023 | Series A | $65,333,745 | |
| November, 07 ,2025 | Series B | $141,000,000.00 |
Atlas Venture
Sofinnova Partners
Forbion
Longwood Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
